Icon Plc (ICLR)

About Icon Plc

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 414 institutions reported holding ICLR, with 80.2 million shares worth $13.8 billion in aggregate. The largest reported holders were Artisan Partners, Wellington Management and FMR. Of the 5 largest reported holders, 4 added shares and 1 reduced its position during the quarter.

More on ICLR

• ICLR sentiment: whether news and social coverage of Icon Plc leans bullish or bearish, and the stories driving it.
• ICLR ownership: all 414 reporting institutions, plus insider and congressional trades.
• ICLR financials: revenue, net income, operating margin and free cash flow by quarter and year.

SentiSense also tracks daily options readings for Icon Plc: IV rank, put/call percentile, 25-delta skew and open-interest walls.

Frequently asked questions